These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

576 related articles for article (PubMed ID: 9040491)

  • 41. Intraarterial urokinase produces significant attenuation of infarction volume in an embolic focal ischemia model.
    Shuaib A; Yang Y; Li Q; Siddiqui MM; Kalra J
    Exp Neurol; 1998 Dec; 154(2):330-5. PubMed ID: 9878171
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of alteplase, a thrombolytic agent, in a rat photothrombotic middle cerebral artery occlusion model.
    Umemura K; Higo K; Sakata T; Yuki S; Iwata K; Yamaguchi K
    Pathophysiol Haemost Thromb; 2008; 36(5):245-50. PubMed ID: 19996634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Experimental cerebral venous thrombosis: evaluation using magnetic resonance imaging.
    Röther J; Waggie K; van Bruggen N; de Crespigny AJ; Moseley ME
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1353-61. PubMed ID: 8898711
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Experimental modeling of recombinant tissue plasminogen activator effects after ischemic stroke.
    El Amki M; Lerouet D; Coqueran B; Curis E; Orset C; Vivien D; Plotkine M; Marchand-Leroux C; Margaill I
    Exp Neurol; 2012 Dec; 238(2):138-44. PubMed ID: 22921458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differences in clot preparation determine outcome of recombinant tissue plasminogen activator treatment in experimental thromboembolic stroke.
    Niessen F; Hilger T; Hoehn M; Hossmann KA
    Stroke; 2003 Aug; 34(8):2019-24. PubMed ID: 12843350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [A new model of middle cerebral artery thrombosis in rats].
    Umemura K; Nakashima M
    Yakubutsu Seishin Kodo; 1993 Feb; 13(1):9-17. PubMed ID: 8317177
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of hypothermia on transient focal ischemia in rat brain evaluated by diffusion- and perfusion-weighted NMR imaging.
    Jiang Q; Chopp M; Zhang ZG; Helpern JA; Ordidge RJ; Ewing J; Jiang P; Marchese BA
    J Cereb Blood Flow Metab; 1994 Sep; 14(5):732-41. PubMed ID: 8063869
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Local cerebral blood flow in a rat cortical vein occlusion model.
    Nakase H; Heimann A; Kempski O
    J Cereb Blood Flow Metab; 1996 Jul; 16(4):720-8. PubMed ID: 8964813
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cerebroprotective effects of TAK-937, a novel cannabinoid receptor agonist, in permanent and thrombotic focal cerebral ischemia in rats: therapeutic time window, combination with t-PA and efficacy in aged rats.
    Murakami K; Suzuki M; Suzuki N; Hamajo K; Tsukamoto T; Shimojo M
    Brain Res; 2013 Aug; 1526():84-93. PubMed ID: 23791950
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Focal cerebral ischemia in rats produced by intracarotid embolization with viscous silicone.
    Lauer KK; Shen H; Stein EA; Ho KC; Kampine JP; Hudetz AG
    Neurol Res; 2002 Mar; 24(2):181-90. PubMed ID: 11877903
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A simple and reproducible cerebral thrombosis model in rats induced by a photochemical reaction and the effect of a plasminogen-plasminogen activator chimera in this model.
    Matsuno H; Uematsu T; Umemura K; Takiguchi Y; Asai Y; Muranaka Y; Nakashima M
    J Pharmacol Toxicol Methods; 1993 Jun; 29(3):165-73. PubMed ID: 8364230
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Thrombolytic efficacy of a modified tissue-type plasminogen activator, SUN9216, in the rat middle cerebral artery thrombosis model.
    Umemura K; Toshima Y; Nakashima M
    Eur J Pharmacol; 1994 Sep; 262(1-2):27-31. PubMed ID: 7813575
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potassium-induced cortical spreading depressions during focal cerebral ischemia in rats: contribution to lesion growth assessed by diffusion-weighted NMR and biochemical imaging.
    Busch E; Gyngell ML; Eis M; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1996 Nov; 16(6):1090-9. PubMed ID: 8898680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diffusion/perfusion MRI study on cerebral ischemia in a rat embolism model].
    Tsuura M
    No To Shinkei; 1996 Jul; 48(7):659-66. PubMed ID: 8753002
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A translationally relevant thromboembolic stroke model for the study of secondary hemorrhage after thrombolysis in rats.
    Sun L; Zhou W; Heiland S; Marti HH; Veltkamp R
    Brain Res; 2011 Jan; 1368():346-54. PubMed ID: 20974110
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The clot thickens--thrombolysis and combination therapies.
    Chopp M; Zhang RL; Zhang ZG; Jiang Q
    Acta Neurochir Suppl; 1999; 73():67-71. PubMed ID: 10494344
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Thrombolytic therapy in experimental embolic stroke.
    Overgaard K
    Cerebrovasc Brain Metab Rev; 1994; 6(3):257-86. PubMed ID: 7811566
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of a TAFI-inhibitor combined with a suboptimal dose of rtPA in a murine thromboembolic model of stroke.
    Durand A; Chauveau F; Cho TH; Kallus C; Wagner M; Boutitie F; Maucort-Boulch D; Berthezène Y; Wiart M; Nighoghossian N
    Cerebrovasc Dis; 2014; 38(4):268-75. PubMed ID: 25401979
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Posttreatment with low molecular weight heparin reduces brain edema and infarct volume in rats subjected to thrombotic middle cerebral artery occlusion.
    Li PA; He QP; Siddiqui MM; Shuaib A
    Brain Res; 1998 Aug; 801(1-2):220-3. PubMed ID: 9729398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.